Sanofi's Deal With Actelion Could Face Battle Over Price

Sanofi’s attempts to acquire Actelion could hit the same roadblock as similar moves by Johnson & Johnson: price

from WSJ.com: US Business http://ift.tt/2hviOVG
via IFTTT